Stay updated with breaking news from Primary Immunodeficiencies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
EQS-News: Biotest AG / Key word: Quarter Results Biotest increased sales by 83.6% to Euro 215.2 million in first quarter 2024 07.05.2024 / 09:00 CET/CEST The issuer is...
Insightful Analysis on KORU Medical's Financial Performance and Strategic Directions
Rising cases of undiagnosed immune deficiency in Indian children underscore urgent need for awareness and early diagnosis.
Children and adults with rare, deadly genetic diseases have fresh hope for curative therapies, thanks to a new collaboration between the Innovative Genomics Institute (IGI) and Danaher Corporation, a global life sciences and diagnostics innovator.The
Dutch biopharmaceutical company Pharming Group N.V. (PHAR) announced Wednesday its plans to develop leniolisib for additional primary immunodeficiencies or PIDs beyond activated phosphoinositide 3-kinase delta syndrome or APDS.